Critical illness polyneuromyopathy

American Journal of Health-System Pharmacy

Volumn 69, Issue 14, 2012, Pages 1199-1205

  Confer, Jennifer ^a,b   Wolcott, Janet ^c   Hayes, Robert ^d  

^a Cabell Huntington Hospital   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c MARSHALL UNIVERSITY   (United States)

^d Our Lady of Bellefonte Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GLUCOSE MONITORING; CRITICAL ILLNESS POLYNEUROMYOPATHY; CRITICALLY ILL PATIENT; ELECTROMYOGRAPHY; ELECTRONEUROGRAPHY; INTENSIVE CARE; MYOPATHY; NEUROMUSCULAR DISEASE; NUTRITION; PATHOPHYSIOLOGY; POLYNEUROPATHY; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84863895012     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110343     Document Type: Review

References (40)

1. Latronico N, Rasulo FA. Presentation and management of ICU myopathy and neuropathy. Curr Opin Crit Care. 2010; 16:123-7.
2. Bolton CF, Gilbert JJ, Hahn AF et al. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 1984; 47:1223-31. (Pubitemid 15204538)
3. Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care. 2005; 11:126-32. (Pubitemid 40488611)
4. Pati S, Goodfellow JA, Iyadurai S et al. Approach to critical illness polyneuropathy and myopathy. Postgrad Med J. 2008; 84:354-60.
5. Garnacho-Montero J, Amaya-Villar R, García-Garmendía JL et al. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med. 2005; 33:349-54. (Pubitemid 40216548)
6. Zink W, Kollmar R, Schwab S. Critical illness polyneuropathy and myopathy in the intensive care unit. Nat Rev Neurol. 2009; 5:372-9.
7. Van Mook WN, Hulsewé-Evers RP. Critical illness polyneuropathy. Curr Opin Crit Care. 2002; 8:302-10.
8. Zochodne DW, Bolton CF, Wells GA et al. Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. Brain. 1987; 110:819-41.
9. Hund E. Neurologic complications of sepsis: critical illness polyneuropathy and myopathy. J Neurol. 2001; 248:929-34. (Pubitemid 36124716)
10. Visser LH. Critical illness polyneuropathy and myopathy: clinical features, risk factors and prognosis. Eur J Neurol. 2006; 13:1203-12. (Pubitemid 44581466)
11. Fulbright RK, Erdum E, Sze G et al. Cranial nerve enhancement in the Guillain-Barré syndrome. Am J Neuroradiol. 1995; 16(suppl 4):923-5.
12. Grob D, Brunner N, Namba T et al. Lifetime course of myasthenia gravis. Muscle Nerve. 2008; 37:141-9. (Pubitemid 351214160)
13. Rudis MI, Guslits BJ, Peterson EL et al. Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit. Crit Care Med. 1996; 24:1749-56. (Pubitemid 26347392)
14. Hermans G, Vanhorebeek I, Derde S et al. Metabolic aspects of critical illness polyneuromyopathy. Crit Care Med. 2009; 37(suppl 10):S391-7.
15. Hermans G, De Jonghe B, Bruyninckx F et al. Clinical review: critical illness polyneuropathy and myopathy. Crit Care. 2008; 12:238-47.
16. Latronico N, Guarneri B. Critical illness myopathy and neuropathy. Minerva Anestesiol. 2008; 74:319-23. (Pubitemid 352037798)
17. Dhand UK. Clinical approach to the weak patient in the intensive care unit. Respir Care. 2006; 51:1024-40. (Pubitemid 44870534)
18. Young GB, Hammond RR. A stronger approach to weakness in the intensive care unit. Crit Care. 2004; 8:416-8. (Pubitemid 40073669)
19. Marinelli WA, Leatherman JW. Neuromuscular disorders in the intensive care unit. Crit Care Clin. 2002; 18:915-29. (Pubitemid 35215568)
20. Leijten FS, de Weerd AW. Critical illness polyneuropathy. A review of the literature, definition and pathophysiology. Clin Neurol Neurosurg. 1994; 96:10-9.
21. Paternostro-Sluga T, Grim-Stieger M, Posch M et al. Reliability and validity of the Medical Research Council (MRC) scale and a modified scale for testing muscle strength in patients with radial palsy. J Rehabil Med. 2008; 40:665-71.
22. James MA. Use of the Medical Research Council muscle strength grading system in the upper extremity. J Hand Surg Am. 2007; 32A:154-6. (Pubitemid 46195166)
23. De Jonghe B, Sharshar T, Lefaucheur JP et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002; 288:2859-67. (Pubitemid 35425072)
24. Kane SL, Dasta JF. Clinical outcomes of critical illness polyneuropathy. Pharmacotherapy. 2002; 22:373-9. (Pubitemid 34205173)
25. Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359-67.
26. Van den Berghe G, Wilmer A, Hermans G et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354:449-61. (Pubitemid 43200296)
27. Hermans G, Wilmer A, Meersseman W et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med. 2007; 175:480-9. (Pubitemid 46354252)
28. Hermans G, Schrooten M, Van Damme P et al. Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study. Crit Care. 2009; 13(1):R5.
29. Finfer S, Chittock DR, Su SY et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009; 360:1283-97.
30. Herridge MS, Cheung AM, Tansey CM et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003; 348:683-93. (Pubitemid 36237037)
31. Hough CL, Steinberg KP, Taylor Thompson B et al. Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med. 2009; 35:63-8.
32. Annane D, Sébille V, Charpentier C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002; 288:862-71.
33. Sprung CL, Annane D, Keh D et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008; 358:111-24.
34. Deem S, Lee CM, Curtis JR. Acquired neuromuscular disorders in the intensive care unit. Am J Respir Crit Care Med. 2003; 168:735-9. (Pubitemid 37188296)
35. Segredo V, Caldwell JE, Matthay MA et al. Persistent paralysis in critically ill patients after long-term administration of vec-uronium. N Engl J Med. 1992; 327:524-8.
36. Papazian L, Forel JM, Gacouin A et al. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med. 2010; 363:1107-16.
37. Schweickert WD, Hall J. ICU-acquired weakness. Chest. 2007; 131:1541-9. (Pubitemid 46762364)
38. Kress JP, Pohlman AS, O'Connor MF et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000; 342:1471-7. (Pubitemid 30318270)
39. Girard TD, Kress JP, Fuchs BD et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008; 371:126-34.
40. Schweickert WD, Pohlman MC, Pohlman AS et al. Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet. 2009; 373:1874-82.